SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022605
Filing Date
2022-11-07
Accepted
2022-11-07 16:12:17
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20220930.htm   iXBRL 10-Q 5090428
2 EX-31.1 fgen-ex31_1.htm EX-31.1 12063
3 EX-31.2 fgen-ex31_2.htm EX-31.2 12040
4 EX-32.1 fgen-ex32_1.htm EX-32.1 12387
  Complete submission text file 0000950170-22-022605.txt   16003028

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fgen-20220930_def.xml EX-101.DEF 296505
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20220930_lab.xml EX-101.LAB 519831
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fgen-20220930_cal.xml EX-101.CAL 65788
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20220930.xsd EX-101.SCH 74371
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20220930_pre.xml EX-101.PRE 448887
63 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20220930_htm.xml XML 3719512
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 221365553
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences